1. Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behavior
    Henry D. Reyes et al, 2019, Scientific Reports CrossRef
  2. Precision gynecologic oncology: circulating cell free DNA epigenomic analysis, artificial intelligence and the accurate detection of ovarian cancer
    Ray O. Bahado-Singh et al, 2022, Scientific Reports CrossRef
  3. Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma
    Ivana Baranova et al, 2020, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
  4. Cell lineage-specific methylome and genome alterations in gout
    Chia-Chun Tseng et al, 2021, Aging CrossRef
  5. Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
    Victoria Tserpeli et al, 2021, Cancers CrossRef
  6. Electrochemical Detection of Global DNA Methylation Using Biologically Assembled Polymer Beads
    Narshone Soda et al, 2021, Cancers CrossRef
  7. LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer
    Li-yuan Feng et al, 2021, Journal of Ovarian Research CrossRef
  8. DNA Methylation in Cancer Epigenetics
    Ewelina A. Klupczyńska, 2023, Epigenetics - Regulation and New Perspectives CrossRef
  9. Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis
    Xueyu Wang et al, 2021, Cancers CrossRef
  10. Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors
    Mangala Hegde et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  11. Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance
    Zachary R. Visco et al, 2021, Frontiers in Oncology CrossRef
  12. Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature
    Xiaoyue M. Guo et al, 2021, Cancers CrossRef
  13. PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
    Maddison Rose et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  14. Development of a novel transcription factors-related prognostic signature for serous ovarian cancer
    He Li et al, 2021, Scientific Reports CrossRef
  15. Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples
    Dana Dvorská et al, 2019, International Journal of Molecular Sciences CrossRef
  16. PPAR-α Modulators as Current and Potential Cancer Treatments
    Yan Tan et al, 2021, Frontiers in Oncology CrossRef
  17. Differential expression analysis in ovarian cancer: A functional genomics and systems biology approach
    Yinbing Zhang et al, 2021, Saudi Journal of Biological Sciences CrossRef